Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Immunotherapy in HIV Infected Persons Using Vaccines after Multi-Drug Treatment

  • Read more about Immunotherapy in HIV Infected Persons Using Vaccines after Multi-Drug Treatment
US Application 60/146,240
Filed on 1999-07-28

Antiviral Genetic Target Within HIV GAG-POL Transframe Region

  • Read more about Antiviral Genetic Target Within HIV GAG-POL Transframe Region
US Application 60/141,072
Filed on 1999-06-25

Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector

  • Read more about Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector
US Application 60/137,126
Filed on 1999-05-28

IDENTIFICATION OF INHIBITORS OF THE HGF-MET uPA-PLASMIN NETWORK USING A NOVEL CELLULAR ASSAY

  • Read more about IDENTIFICATION OF INHIBITORS OF THE HGF-MET uPA-PLASMIN NETWORK USING A NOVEL CELLULAR ASSAY
US Application 60/130,613
Filed on 1999-04-22

Peptides and Their Utility in Modulation of Behavior of Cells Expressing Alpha 3 Beta 1 Integrins

  • Read more about Peptides and Their Utility in Modulation of Behavior of Cells Expressing Alpha 3 Beta 1 Integrins
US Application 60/144,549
Filed on 1999-07-15

T20/DP178 And T21/DP107 Are Activators of Human Phagocyte Formyl Peptide Receptors

  • Read more about T20/DP178 And T21/DP107 Are Activators of Human Phagocyte Formyl Peptide Receptors
US Application 60/132,686
Filed on 1999-05-05

Method of Reversing Chemotherapeutic Drug Resistance in tumor or Cancer Cells Utilizing an Acidically-Modified Dominant Negative

  • Read more about Method of Reversing Chemotherapeutic Drug Resistance in tumor or Cancer Cells Utilizing an Acidically-Modified Dominant Negative
US Application 60/138,864
Filed on 1999-06-11

Reduction of the Nonspecific Animal Toxicity of Immunotoxin by Mutat- ing the framework regions of the Fv to Lower the Isoelectic Point

  • Read more about Reduction of the Nonspecific Animal Toxicity of Immunotoxin by Mutat- ing the framework regions of the Fv to Lower the Isoelectic Point
US Application 60/249,805
Filed on 2000-11-17

IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY Affinity Improvement of scFVsr ab's w/higher affinity for Mesothelin

  • Read more about IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY Affinity Improvement of scFVsr ab's w/higher affinity for Mesothelin
US Application 60/160,071
Filed on 1999-05-27

Leukocyte Derived Anti-Viral Factors

  • Read more about Leukocyte Derived Anti-Viral Factors
US Application 60/162,262
Filed on 1999-10-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 202
  • Page 203
  • Page 204
  • Page 205
  • Page 206
  • Page 207
  • Page 208
  • Page 209
  • Page 210
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health